You Are Here :
Cerviron vaginal ovules contain 7 active components that confer their beneficial therapeutic properties in multiple disorders or the female genital tract.
Goro Healthcare partners with Demophorius in the UAE and Qatar
Goro Healthcare launches Neopausil® in the United Arab Emirates
Tanyx® obtain MOHAP registration approval
Goro Healthcare signs an exclusive distribution agreement with The OTClab and Perfect Care Phamra
Preliminary results from Russian trials find that vaccine candidates led to no serious adverse events and elicit antibody response
FDA announces first of its kind program to communicate patient reported outcomes from oncology clinical trials